The Role of CAR T Persistence in Therapeutic Efficacy

The Best of CAR T at the 2026 Tandem Meetings webinar is the second in a two-part CAR T webinar series. This session will air on Wednesday, December 9 at 3:00pm ET/2:00pm CT and will highlight the ASTCT Spotlight Session The Role of CAR T Persistence in Therapeutic Efficacy from the 2026 Tandem Meetings of ASTCT and CIBMTR. The session is open and free to all ASTCT members and non-members. 

Presentations and Speakers:

CD28 or 4-1BB CAR T: Fitness, Persistence, and Tumor Resistance
Mohamad Hamieh, PhD- Weill Cornell Medicine

Genetic Approaches for Engineering Persistent CAR T Cells
Evan Weber, PhD- Children's Hospital of Philadelphia

Efficacy and Persistence of Allogenic CAR T Cells
Melody Smith, MD, PhD- Stanford University

Thank you to Johnson & Johnson and Legend Biotech for their generous support of this webinar series.